Dr Mittal Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-07-2024
- Paid Up Capital ₹ 3.50 M
as on 25-07-2024
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.83 Cr
as on 25-07-2024
- Revenue -33.86%
(FY 2023)
- Profit -87.49%
(FY 2023)
- Ebitda -126.46%
(FY 2023)
- Net Worth -56.53%
(FY 2023)
- Total Assets -4.88%
(FY 2023)
About Dr Mittal Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company has closed loans amounting to ₹1.83 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ankit Gupta and Akansha Gupta serve as directors at the Company.
- CIN/LLPIN
U24234UR2005PTC031167
- Company No.
031167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dr Mittal Laboratories Private Limited offer?
Dr Mittal Laboratories Private Limited offers a wide range of products and services, including Veterinary Medicines, Anthelmintics, Pharmaceutical Medicine, Antiepileptic Drugs.
Who are the key members and board of directors at Dr Mittal Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Gupta  | Additional Director | 15-Oct-2016 | Current |
| Akansha Gupta | Additional Director | 20-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Dr Mittal Laboratories.
Dr Mittal Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.86% decrease. The company also saw a substantial fall in profitability, with a 87.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Mittal Laboratories?
In 2023, Dr Mittal Laboratories had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunbeam Softek Private LimitedActive 18 years 9 monthsAnkit Gupta and Akansha Gupta are mutual person
- Brisk Softek Private LimitedActive 18 years 9 months
Ankit Gupta and Akansha Gupta are mutual person
- Israni Retails Private LimitedActive 21 years 8 days
Ankit Gupta and Akansha Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 12 Feb 2009 | ₹1.00 M | Satisfied |
Punjab National Bank Creation Date: 22 Nov 2008 | ₹0.75 M | Satisfied |
Punjab National Bank Creation Date: 03 Oct 2006 | ₹5.00 M | Satisfied |
How Many Employees Work at Dr Mittal Laboratories?
Unlock and access historical data on people associated with Dr Mittal Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Mittal Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Mittal Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
